Evaluation of a directly observed six month fully intermittent treatment regimen for tuberculosis in patients suspected of poor compliance

Thorax

Volumn 51, Issue 11, 1996, Pages 1130-1133

  Caminero, J A ^a   Pavon J M ^a   Rodriguez De Castro F ^a   Diaz F ^a   Julia G ^a   Cayla J A ^b   Cabrera, P ^a  

^a UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

^b INSTITUT CATALÀ DE LA SALUT   (Spain)

Author keywords

Compliance; Directly observed intermittent therapy; Tuberculosis

Indexed keywords

ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PATIENT COUNSELING; PRIORITY JOURNAL; TUBERCULOSIS; ADOLESCENT; ALCOHOLISM; DRUG ADMINISTRATION; HOMELESSNESS; MIDDLE AGED; PSYCHOLOGICAL ASPECT; RISK FACTOR; SUBSTANCE ABUSE; TREATMENT REFUSAL;

ADOLESCENT; ADULT; ALCOHOLISM; ANTITUBERCULAR AGENTS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HOMELESS PERSONS; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; TREATMENT REFUSAL; TUBERCULOSIS;

EID: 0029658088     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.51.11.1130     Document Type: Article

References (36)

1. Enarson DA. Principles of IUATLD collaborative tuberculosis programme. Bull Int Union Tuberc Lung Dis 1991; 66:195-200.
2. World Health Organization. WHO Expert Committee on tuberculosis. Ninth report. Geneva: World Health Organization, 1974.
3. Caminero JA. Medidas básicas para el control de la tuberculosis en una communidad. Med Clin (Barc) 1994;102: 67-73.
4. Chum HJ. The Tanzania National Tuberculosis Leprosy Programme in the face of HIV infection. Bull Int Union Tuberc Lung Dis 1990/1991;66(Suppl):53-5.
5. Arguello L. Results of the tuberculosis control programme in Nicaragua in 1984-1989. Bull Int Union Tuberc Lung Dis 1990/1991;66(Suppl):51-2.
6. Medical Research Council Tuberculosis and Chest Diseases Unit. Treatment of pulmonary tuberculosis in patients notified in England and Wales in 1978-9: chemotherapy and hospital admission. Thorax 1985;40:113-20.
7. Brudney K, Dobkin J. Resurgent tuberculosis in New York City. Human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs. Am Rev Respir Dis 1991;144:745-9.
8. Prevention and control of tuberculosis among homeless persons. Recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR 1992;41(RR 5): 13-23.
9. Ferrer X, Kirschbaum A, Toro J, Jadue J, Munoz M, Espinoza A. Compliance with tuberculosis treatment in adults in Santiago, Chile. Bol Sanit Panam 1991;111: 423-31.
10. Joint Tuberculosis Committee of the British Thoracic Society. Control and prevention of tuberculosis in the United Kingdom: code of practice 1994. Thorax 1994;49:1193-200.
11. Jindani A, Aber VR, Edwards EA, Mitchison DA. The early bactericidal activity of drugs in patients with pulmonary tuberculosis. Am Rev Respir Dis 1980;121:939-49.
12. Mitchison DA. Basic mechanisms of chemotherapy. Chest 1979;76(Suppl):771-81.
13. Subcommittee of the Joint Tuberculosis Committee. Chemotherapy and management of tuberculosis in the United Kingdom; recommendations of the Joint Tuberculosis Committee of the British Thoracic Society. Thorax 1990;45:403-8.
14. American Thoracic Society. Treatment of tuberculosis and tuberculosis infection in adults and children. Am J Respir Crit Care Med 1994;149:1359-74.
15. International Union Against Tuberculosis and Lung Diseases. Committee of Treatment. Bull Int Union Tuberc Lung Dis 1988;63:64.
16. World Heath Organisation. Treatment of tuberculosis. Guidelines for national programmes. Geneva: World Health Organization, 1993.
17. Caminero JA, González A, Rodriguez de Castro F, Juliá G, Fernández JM, Cabrera P. Epidemiologia de las resistencias bacilares en la isla de Gran Canaria. Arch Bronconeumol 1991;27:17-22.
18. Ministerio de Sanidad y Consumo. Grupo de trabajo sobre tuberculosis. Consenso nacional para el control de la tuberculosis en España. Med Clin (Barc) 1992;98:24-31.
19. Canetti G, Rist N, Grosset J. Mesure de la sensibilite du bacille tuberculeux aux drogues antibacilaires par le methode des proportions. Rev Tuberc Pneumol 1963;27: 263-72.
20. Second East African British Medical Research Council study. Controlled clinical trial of four short-course (6 month) regimens of chemotherapy for treatment of pulmonary tuberculosis. Lancet 1974;ii:1100-6.
21. Second East African British Medical Research Council study. Controlled clinical trial of four short-course (6 month) regimens of chemotherapy for treatment of pulmonary tuberculosis. Second report. Am Rev Respir Dis 1976;114:471-5.
22. Hong Kong Chest Service/British Medical Research Council. Controlled trial of six-month and eight-month regimens in the treatment of pulmonary tuberculosis. First report. Am Rev Respir Dis 1978;118:219-27.
23. Hong Kong Chest Service British Medical Research Council. Controlled trial of four twice-weekly regimens and daily regimen all given for six months for pulmonary tuberculosis. Lancet 1981;i:171-4.
24. Hong Kong Chest Service/British Medical Research Council. Controlled trial of four three times weekly regimens and daily regimen all given for six months for pulmonary tuberculosis. Tubercle 1982;63:89-98.
25. Hong Kong Chest Service British Medical Research Council. Five year follow-up of a controlled trial of five six-month regimens of chemotherapy for pulmonary tuberculosis. Rev Respir Dis 1987;136:1339-42.
26. Eule H, Beck H, Evers A. Daily and intermittent short-course chemotherapy using four drugs in recently detected bacillary pulmonary tuberculosis. Bull Int Union Tuberc Lung Dis 1982;52:63.
27. Prabhakar H. Fully intermittent six-month regimen for pulmonary tuberculosis in South India. Bull Int Union Tuberc Dis 1987;62:21-3.
28. Paramasivan CN, Chandrasekaran V, Santha T, Sudarsanan NM, Prabhakar R. Bacteriological investigations for short-course chemotherapy under the tuberculosis programme in two districts of India. Tuberc Lung Dis 1993;74:23-7.
29. Datta M, Radhamani MP, Selvarag R, Paramasivan CN, Gopalan BN, Sudeendra CR, et al. Clinical assessment of smear-positive pulmonary tuberculosis patients after chemotherapy under the district tuberculosis programme. Tuberc Lung Dis 1993;74:180-6.
30. Giullani RW, Hamburg MA. New tuberculosis cases declined in 1993, Department of Health announces. New York: News of the Department of Health of New York, 1994.
31. Frieden TR, Fujiwara PI, Washko RM, Hamburg MA. Tuberculosis in New York city. Turning the tide. N Engl J Med 1995;333:229-33.
32. Caminero JA. Elaboración de un programa de control de la tuberculosis en la isla de Gran Canaria. Universidad de Las Palmas (España): Doctoral thesis, 1993.
33. Caylá JA, Galdós-Tangüis H, Garcia de Olalla P, Rodrigo T, Brugal MT, Jansá JM. La tuberculosis en Barcelona. Informe 1993. Barcelona: Publicaciones del Institut Municipal de la Salut, 1994.
34. American Thoracic Society. Guidelines for short-course tuberculosis chemotherapy. Am Rev Respir Dis 1980;121: 611-4.
35. Nyangulu DS. The point of view of a high prevalence country: Malawi. Bull Int Union Tuberc Lung Dis 1991;66: 173-4.
36. Salomao MA. The national tuberculosis control programme in Mozambique, 1985-1990. Bull Int Union Tuberc Lung Dis 1991;66:175-80.